These medications contain the active ingredient tirzepatide, which works similarly to semaglutide and other GLP-1s
These are key definitions used throughout this analysis
The most commonly reported adverse events were gastrointestinal in nature including nausea, vomiting, diarrhoea, and constipation a profile consistent with other incretin-based therapies
If you experience any of these symptoms, contact your healthcare provider immediately or seek urgent medical attention
For weight loss, the initial dose of Wegovy is usually 0.25 mg once weekly for the first four weeks
Diabetes Obes Metab 20:22102219 Husain M, Birkenfeld AL, Donsmark M et al (2019) Oral semaglutide and cardiovascular outcomes in patients with type 2 diabetes